Meyka Pro banner
Illumina, Inc.

Illumina, Inc. (ILMN) Stock Overview

Explore Illumina, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ILMNNASDAQ
HealthcareMedical - Diagnostics & Research
$224.99
$1.77(0.79%)
U.S. Market opens in NaNh NaNm

Illumina, Inc. (ILMN)

Meyka AI Score

Z

Key Financials

Market Cap34B
P/E Ratio41.63
EPS (TTM)$5.03
ROE0.31%
Fundamental Analysis

AI Price Forecasts

1 Month$201.56
3 Months$175.71
1 Year Target$61.56

ILMN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Illumina, Inc. (NASDAQ: ILMN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Illumina, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ILMN on the NASDAQ shows an RSI of 72.62, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $61.56 for the NASDAQ listing.

Key metrics behind Illumina, Inc.'s NASDAQ-traded stock include a P/E ratio of 41.63 and a market capitalization of 34B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ILMN on the NASDAQ.

Price Performance (NASDAQ: ILMN)

1-Day Change
0.79%
5-Day Change
12.33%
1-Month Change
15.92%
3-Month Change
54.92%
6-Month Change
84.61%
Year-to-Date (YTD) Change
71.54%
1-Year Change
125.76%
3-Year Change
46.45%
5-Year Change
-52.51%
All-Time (Max) Change
1082.29%

Contact Information

858 202 4500
5200 Illumina Way, San Diego, CA, 92122

Company Facts

86,000 Employees
IPO DateJul 28, 2000
CountryUS
Actively Trading

Frequently Asked Questions